This is important: The flu vaccine is recommended for those with HBV and HCV—Alan Franciscus.
25, 2013 — New research out of St. Michael’s Hospital has found that
despite popular belief, the flu shot is effective in preventing the flu,
even if the virus going around does not match the vaccine.
quite common for people to say they are not going to get the flu shot
this year because they’ve heard it does not match the strain of flu
going around,” said Dr. Andrea Tricco, the lead author of the paper and a
scientist at the Li Ka Shing Knowledge Institute of St. Michael’s
Hospital. “However, we’ve found that individuals will be protected
regardless of whether the flu strain is a match or not.”
Only 11 percent of the 79 million Americans with prediabetes aware they have the condition
This is article is not directly related to HCV although it has been
well-documented that the hepatitis C virus causes insulin resistance (a
precursor to diabetes). Because of the link to HCV and the number of people
with HCV who also have diabetes it is important that everyone with HCV
should be evaluated by their medical provider for diabetes –Alan
THURSDAY, March 21 (HealthDay News) — Only 11 percent of the
estimated 79 million Americans who are at risk for diabetes know they
are at risk, federal health officials reported Thursday.
The condition, known as prediabetes, describes
higher-than-normal blood sugar levels that put people in danger of
developing diabetes, according to the U.S. Centers for Disease Control
While psychological illness and alcohol consumption can reduce
treatment response in patients with chronic hepatitis C, the effect of
other behavioral and lifestyle factors remains unclear, according to a
Researchers performed a systematic review of 34 studies, conducted
between 1994 and 2011, evaluating the impact of social, lifestyle and
psychological factors on sustained virologic response (SVR) to treatment
for chronic hepatitis C (CHC).
Patients with chronic HCV who responded to treatment with pegylated
interferon and ribavirin experienced a subsequent improvement to
neurocognitive performance in a recent study.
Using the Test for Attentional Performance (TAP), researchers
evaluated the neurocognitive capabilities of 168 adult patients with hepatitis C
before and after weekly treatment with peginterferon alfa-2b and
weight-based ribavirin for 24 or 48 weeks. Participants took the
computer-aided TAP test at baseline and 12 months or longer (range 12 to
48 months) after completing therapy.
Alan is the founder of the HCV Advocate website and started the HCV training workshops certification program.
There is a very good argument to be made that Alan Franciscus is the
most significant trailblazer in his work for hepatitis C awareness and
advocacy movement in the United States. Since the existence of hepatitis
C as a distinct virus was not even proven until 1989, the movement has
been in existence for only about twenty odd years, and it has been far
from a powerful entity in terms of public awareness and reach. In fact, a
good deal of what has been accomplished has been accomplished by Alan
Franciscus. And the man doesn’t even have a Wikipedia page.
Diagnosed with HCV in 1996, a manner in which Alan chose to deal with
his diagnosis turned out to be a response that would go on to help
countless people. In 1997, Alan founded the Hepatitis C Support Project
(HCSP) to help support and advocate for people affected by hepatitis C,
hepatitis B, and HIV and hepatitis coinfections. HCSP has generated
several essential support services and informational resources that have
become an invaluable part of the current HCV landscape in America.
Canadian women coinfected with hepatitis C
virus (HCV) and HIV had a significantly lower cognitive composite index
(CCI) than comparison groups of women infected only with HIV and women
infected with neither virus.1 Cognitive scores did not differ
significantly between the HIV-positive/HCV-negative group and the
Research has not assessed cognitive function in HIV-positive women as
thoroughly as in HIV-positive men. Even less is known about the
potential dual impact of HCV and HIV on cognitive function in women. To
address these issues, researchers conducted this study in HIV-positive
and negative women attending the Oak Tree Clinic in Vancouver, British
Most of the really big changes made by the 2010 health law don’t start for another year. That includes things like a ban
on restricting pre-existing conditions, and required insurance coverage
for most Americans. But Jan. 1, 2013, will nevertheless mark some major
One of those changes that will affect everyone with
private health insurance actually took effect last September. But most
people won’t see it until they renew or apply for new health insurance.
It’s called a summary of benefits and coverage. The idea is to help people actually understand what’s in their insurance policies.
A large number of patients with chronic hepatitis C are vitamin A
deficient, and this deficiency is associated with nonresponse to
treatment, according to recent results.
In a multicenter study, researchers compared the serum vitamin A and vitamin D levels in 199 treatment-naive patients with chronic hepatitis C, before receiving interferon (IFN)-based antiviral therapy, with those of 119 healthy controls.